Our protocols take on board this highly significant point, because implant-wearing patients who commence treatment with antiresorptives should be warned that the risk of suffering ONJ will always exist owing to the very presence of the implant, and not just by its placement, therefore one way of preventing it would be not to place implants in any patient who is to be treated or is being treated with these drugs.
← all excerpts
Proposal for a preventive protocol for medication-related osteonecrosis of the jaw.
1
—
—